SCHEMBL22348156

SCHEMBL22348156

Cc1nc(C23CCC(CC4(C(=O)Nc5cccc(/C=C/C(=O)O)c5)CCCCC4)(CC2)CC3)no1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 5/20 0.41
MEN1 O00255 4/20 0.41
CYP2C9 P11712 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.39
NR1H4 Q96RI1 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
S1PR1 P21453 1/20 0.36
RHOA P61586 3/20 0.35
IP6K1 Q92551 1/20 0.34
IP6K3 Q96PC2 1/20 0.34
IP6K2 Q9UHH9 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
ITGB3 P05106 1/20 0.33
ITGB1 P05556 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22347990 0.87 NR1H4 (0.50) GLAMAPTKMT2AMEN1CYP2C9
SCHEMBL22347965 0.83 GLA (0.43) GLAMAPTKMT2AMEN1CYP2C9
SCHEMBL22348173 0.81 NR1H4 (0.52) CYP2C9NR1H4CYP2C19
SCHEMBL22348637 0.80 NR1H4 (0.49) GLAMAPTKMT2AMEN1CYP2C9
SCHEMBL22348042 0.80 NR1H4 (0.49) CYP2C9NR1H4CYP2C19
SCHEMBL29900958 0.75 NR1H4 (0.46) MAPTKMT2AALDH1A1NR1H4IP6K1
SCHEMBL22350196 0.75 NR1H4 (0.46) MAPTKMT2AALDH1A1NR1H4IP6K1
SCHEMBL22347743 0.74 THRB (0.44) GLAMAPTKMT2AMEN1ALDH1A1
SCHEMBL22348121 0.73 NR1H4 (0.65) CYP2C9NR1H4CYP2C19
SCHEMBL18641074 0.73 GLA (0.42) GLAMAPTKMT2AMEN1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3924329-A2 SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS Bristol-Myers Squibb Company (US) 2021-12-22 EP disclosed
WO-2020168152-A2 SUBSTITUTED AMIDE COMPOUNDS USEFUL AS FARNESOID X RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2020-08-20 WO disclosed